Option Care Health (NASDAQ:OPCH) Shares Down 6% Following Analyst Downgrade

Option Care Health, Inc. (NASDAQ:OPCH - Get Free Report)'s stock price fell 6% on Monday after The Goldman Sachs Group downgraded the stock from a buy rating to a neutral rating. The Goldman Sachs Group now has a $27.00 price target on the stock. Option Care Health traded as low as $22.66 and last traded at $22.66. 176,542 shares traded hands during mid-day trading, a decline of 88% from the average session volume of 1,467,324 shares. The stock had previously closed at $24.11.

Several other research firms have also issued reports on OPCH. JMP Securities lifted their target price on shares of Option Care Health from $36.00 to $37.00 and gave the company a "market outperform" rating in a report on Monday, September 30th. Jefferies Financial Group cut Option Care Health from a "buy" rating to a "hold" rating and lowered their price objective for the company from $38.00 to $26.00 in a research note on Thursday. Barrington Research cut their target price on Option Care Health from $40.00 to $32.00 and set an "outperform" rating on the stock in a research note on Thursday. Truist Financial lowered their price target on Option Care Health from $41.00 to $34.00 and set a "buy" rating for the company in a research report on Friday. Finally, Bank of America downgraded shares of Option Care Health from a "buy" rating to a "neutral" rating and cut their price objective for the company from $43.00 to $29.00 in a research report on Wednesday, October 30th. Three research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. According to data from MarketBeat.com, Option Care Health presently has an average rating of "Moderate Buy" and a consensus target price of $30.83.

Insiders Place Their Bets

In other news, CFO Michael H. Shapiro sold 23,217 shares of the business's stock in a transaction that occurred on Thursday, August 22nd. The shares were sold at an average price of $30.95, for a total transaction of $718,566.15. Following the completion of the transaction, the chief financial officer now directly owns 247,317 shares of the company's stock, valued at $7,654,461.15. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other Option Care Health news, Director Elizabeth Quadros Betten sold 47,531 shares of the firm's stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $31.09, for a total value of $1,477,738.79. Following the transaction, the director now directly owns 21,339 shares of the company's stock, valued at approximately $663,429.51. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO Michael H. Shapiro sold 23,217 shares of the company's stock in a transaction dated Thursday, August 22nd. The shares were sold at an average price of $30.95, for a total transaction of $718,566.15. Following the sale, the chief financial officer now directly owns 247,317 shares of the company's stock, valued at $7,654,461.15. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. 0.64% of the stock is owned by insiders.

Institutional Trading of Option Care Health

Several large investors have recently added to or reduced their stakes in OPCH. Blue Trust Inc. grew its holdings in Option Care Health by 14.8% during the second quarter. Blue Trust Inc. now owns 2,931 shares of the company's stock valued at $81,000 after purchasing an additional 377 shares during the period. GAMMA Investing LLC grew its stake in shares of Option Care Health by 110.6% during the 3rd quarter. GAMMA Investing LLC now owns 897 shares of the company's stock valued at $28,000 after acquiring an additional 471 shares during the period. Trust Point Inc. increased its holdings in Option Care Health by 2.6% in the 3rd quarter. Trust Point Inc. now owns 24,124 shares of the company's stock worth $755,000 after acquiring an additional 622 shares in the last quarter. Nisa Investment Advisors LLC raised its stake in Option Care Health by 5.4% during the 2nd quarter. Nisa Investment Advisors LLC now owns 13,581 shares of the company's stock worth $376,000 after acquiring an additional 690 shares during the period. Finally, State of Alaska Department of Revenue lifted its holdings in Option Care Health by 3.8% during the third quarter. State of Alaska Department of Revenue now owns 19,871 shares of the company's stock valued at $621,000 after purchasing an additional 735 shares in the last quarter. 98.05% of the stock is currently owned by institutional investors.

Option Care Health Trading Down 6.7 %

The firm has a market capitalization of $3.83 billion, a P/E ratio of 18.90, a price-to-earnings-growth ratio of 1.74 and a beta of 1.32. The stock's 50-day simple moving average is $30.31 and its two-hundred day simple moving average is $29.85. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.36.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.